Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study
Related posts
-
Game time: Dave & Buster’s to open at Yorktown Center
Dave & Buster’s is scheduled to open next month at Yorktown Center in Lombard with the... -
Hanover Park parks president speaking out on citation for verbal assault of teen referee
Hanover Park Park District President Mark Elkins is speaking out regarding a Carol Stream citation he... -
Five high school football games to watch this weekend
St. Charles North (3-0) at Batavia (3-0)